Merit Medical Systems (MMSI) Getting Somewhat Favorable Media Coverage, Report Shows

Media headlines about Merit Medical Systems (NASDAQ:MMSI) have been trending somewhat positive recently, Accern Sentiment reports. The research group identifies negative and positive news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Merit Medical Systems earned a coverage optimism score of 0.19 on Accern’s scale. Accern also assigned news articles about the medical instruments supplier an impact score of 46.0139434477585 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Merit Medical Systems (NASDAQ:MMSI) opened at $43.30 on Friday. The company has a market cap of $2,201.22, a PE ratio of 34.53, a PEG ratio of 2.97 and a beta of 1.23. The company has a quick ratio of 1.43, a current ratio of 2.78 and a debt-to-equity ratio of 0.39. Merit Medical Systems has a fifty-two week low of $24.23 and a fifty-two week high of $45.50.

Merit Medical Systems (NASDAQ:MMSI) last posted its earnings results on Wednesday, October 25th. The medical instruments supplier reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.30 by $0.02. The firm had revenue of $179.30 million during the quarter, compared to analysts’ expectations of $181.28 million. Merit Medical Systems had a net margin of 4.06% and a return on equity of 9.86%. The business’s revenue for the quarter was up 14.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.26 earnings per share. equities research analysts forecast that Merit Medical Systems will post 1.27 EPS for the current fiscal year.

Several research firms recently weighed in on MMSI. BidaskClub cut shares of Merit Medical Systems from a “hold” rating to a “sell” rating in a research report on Tuesday, December 5th. ValuEngine cut shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Wells Fargo & Company reaffirmed an “outperform” rating and set a $51.00 price objective (up previously from $46.00) on shares of Merit Medical Systems in a research report on Thursday, November 30th. SunTrust Banks set a $47.00 price objective on shares of Merit Medical Systems and gave the stock a “buy” rating in a research report on Thursday, November 16th. Finally, Zacks Investment Research raised shares of Merit Medical Systems from a “hold” rating to a “buy” rating and set a $43.00 target price for the company in a report on Saturday, October 28th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have issued a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $43.77.

In other news, Director Kent W. Stanger sold 2,918 shares of the stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $44.55, for a total value of $129,996.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders sold 5,518 shares of company stock valued at $239,276 in the last three months. Company insiders own 5.00% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Merit Medical Systems (MMSI) Getting Somewhat Favorable Media Coverage, Report Shows” was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The original version of this piece of content can be accessed at

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Insider Buying and Selling by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related companies with's FREE daily email newsletter.

Leave a Reply